Jason Phua
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jason Phua has a total of 126 co-authors. Here are the top co-authors by number of shared publications:
- Kay Choong See
Division of Respiratory & Critical Care Medicine, Department of Medicine, National University Hospital, Singapore, Singapore
4 shared publications - Amartya Mukhopadhyay
Department of Medicine, Integrated Medicine Programme, Alexandra Hospital, National University Health System, Singapore, Singapore, 65 94247906
3 shared publications - Hui Fang Lim
Department of Respiratory Medicine, National University of Singapore, Singapore, Singapore
3 shared publications Babu Raja Shrestha
Department of Anesthesia and Intensive Care, Kathmandu Medical College and Teaching Hospital, Kathmandu, Nepal
2 shared publicationsJose Emmanuel Palo
Acute and Critical Care Institute, The Medical City, Pasig City, Philippines
2 shared publicationsMadiha Hashmi
Department of Critical Care Medicine, Ziauddin University, Karachi, Pakistan
2 shared publications
Latest Publications
- Open Access
- 11 December 2023
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 44, 100982
Critical care bed capacity in Asian countries and regions before and during the COVID-19 pandemic: an observational study
- 11 December 2023
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 44, 100982
Open AccessCritical care bed capacity in Asian countries and regions before and during the COVID-19 pandemic: an observational study
- Open Access
Sequential Organ Failure Assessment (SOFA) score for predicting mortality in patients with sepsis in Vietnamese intensive care units: A multicentre, cross-sectional study
Objectives: To compare the accuracy of the SOFA and APACHE II scores in predicting mortality among ICU patients with sepsis in an LMIC. Design: A multicentre, cross-sectional study. Setting: A total of 15 adult ICUs throughout Vietnam. Participants: We included all patients aged ≥ 18 years who were admitted to ICUs for sepsis and who were still in ICUs from 00:00 hour to 23:59 hour of the specified study days (i.e., 9 th January, 3 rd April, 3 rd July, and 9 th October of the year 2019). Primary and secondary outcome measures: The primary outcome was hospital all-cause mortality (hospital mortality). We also defined the secondary outcome as all-cause deaths in the ICU (ICU mortality). Results: Of 252 patients, 40.1% died in hospitals, and 33.3% died in ICUs. SOFA (AUROC: 0.688 [95% CI: 0.618-0.758]; cut-off value ≥ 7.5; P AUROC AUROC AUROC AUROC <0.001). A SOFA score ≥ 8 (adjusted OR: 2.717; 95% CI: 1.371-5.382) and an APACHE II score ≥ 21 (adjusted OR: 2.668; 95% CI: 1.338-5.321) were independently associated with an increased risk of hospital mortality. Additionally, a SOFA score ≥ 10 (adjusted OR: 2.194; 95% CI: 1.017-4.735) was an independent predictor of ICU mortality, in contrast to an APACHE II score ≥ 19, for which this role did not. Conclusions: In this study, SOFA and APACHE II scores were worthwhile in predicting mortality among ICU patients with sepsis. However, due to better discrimination for predicting ICU mortality, the SOFA was preferable to the APACHE II score in predicting mortality. Clinical trials registry – India: CTRI/2019/01/016898 Strengths and limitations of this study: An advantage of the present study was data from multi centres, which had little missing data. Due to the absence of a national registry of intensive care units (ICUs) to allow systematic recruitment of units, we used a snowball method to identify suitable units, which might have led to the selection of centres with a greater interest in sepsis management. Due to the study’s real-world nature, we did not make a protocol for microbiological investigations. Moreover, we mainly evaluated resources utilized in ICUs; therefore, the data detailing the point-of-care testing and life-sustaining treatments were not available. Additionally, to improve the feasibility of conducting the study in busy ICUs, we opted not to collect data on antibiotic resistance and appropriateness. Due to our independent variables (e.g., SOFA score that was greater than or equal to the cut-off value) that might be associated with primary outcome only measured upon ICU admission, the mixed-effects logistic regression model could not be used to predict discrete outcome variables measured at two different times, i.e., inside and outside the ICU settings. Although the sample size was large enough, the confidence interval was slightly wide (±6.03%), which might influence the normal distribution of the sample.
Open AccessSequential Organ Failure Assessment (SOFA) score for predicting mortality in patients with sepsis in Vietnamese intensive care units: A multicentre, cross-sectional study
Objectives: To compare the accuracy of the SOFA and APACHE II scores in predicting mortality among ICU patients with sepsis in an LMIC. Design: A multicentre, cross-sectional study. Setting: A total of 15 adult ICUs throughout Vietnam. Participants: We included all patients aged ≥ 18 years who were admitted to ICUs for sepsis and who were still in ICUs from 00:00 hour to 23:59 hour of the specified study days (i.e., 9 th January, 3 rd April, 3 rd July, and 9 th October of the year 2019). Primary and secondary outcome measures: The primary outcome was hospital all-cause mortality (hospital mortality). We also defined the secondary outcome as all-cause deaths in the ICU (ICU mortality). Results: Of 252 patients, 40.1% died in hospitals, and 33.3% died in ICUs. SOFA (AUROC: 0.688 [95% CI: 0.618-0.758]; cut-off value ≥ 7.5; P AUROC AUROC AUROC AUROC <0.001). A SOFA score ≥ 8 (adjusted OR: 2.717; 95% CI: 1.371-5.382) and an APACHE II score ≥ 21 (adjusted OR: 2.668; 95% CI: 1.338-5.321) were independently associated with an increased risk of hospital mortality. Additionally, a SOFA score ≥ 10 (adjusted OR: 2.194; 95% CI: 1.017-4.735) was an independent predictor of ICU mortality, in contrast to an APACHE II score ≥ 19, for which this role did not. Conclusions: In this study, SOFA and APACHE II scores were worthwhile in predicting mortality among ICU patients with sepsis. However, due to better discrimination for predicting ICU mortality, the SOFA was preferable to the APACHE II score in predicting mortality. Clinical trials registry – India: CTRI/2019/01/016898 Strengths and limitations of this study: An advantage of the present study was data from multi centres, which had little missing data. Due to the absence of a national registry of intensive care units (ICUs) to allow systematic recruitment of units, we used a snowball method to identify suitable units, which might have led to the selection of centres with a greater interest in sepsis management. Due to the study’s real-world nature, we did not make a protocol for microbiological investigations. Moreover, we mainly evaluated resources utilized in ICUs; therefore, the data detailing the point-of-care testing and life-sustaining treatments were not available. Additionally, to improve the feasibility of conducting the study in busy ICUs, we opted not to collect data on antibiotic resistance and appropriateness. Due to our independent variables (e.g., SOFA score that was greater than or equal to the cut-off value) that might be associated with primary outcome only measured upon ICU admission, the mixed-effects logistic regression model could not be used to predict discrete outcome variables measured at two different times, i.e., inside and outside the ICU settings. Although the sample size was large enough, the confidence interval was slightly wide (±6.03%), which might influence the normal distribution of the sample.
- Open Access
- 22 June 2020
- Published by Springer Nature in Intensive Care Medicine
- Vol. 46 (8) , 1600-1602
ICU beds: less is more? Not sure
- 22 June 2020
- Published by Springer Nature in Intensive Care Medicine
- Vol. 46 (8) , 1600-1602
Open AccessICU beds: less is more? Not sure
- Top Cited Papers
- 1 May 2020
- Published by Elsevier in The Lancet Respiratory Medicine
- Vol. 8 (5) , 506-517
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations
- 1 May 2020
- Published by Elsevier in The Lancet Respiratory Medicine
- Vol. 8 (5) , 506-517
Top Cited PapersIntensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations
- 1 March 2020
- Published by American Medical Association (AMA) in JAMA Cardiology
- Vol. 5 (3) , 249-250
Heart(beat) to Heart(beat)
This essay describes the author’s experience with interfascicular ventricular tachycardia.
- 1 March 2020
- Published by American Medical Association (AMA) in JAMA Cardiology
- Vol. 5 (3) , 249-250
Heart(beat) to Heart(beat)
This essay describes the author’s experience with interfascicular ventricular tachycardia.
- Open Access
- 28 September 2017
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (9) , e0185212
Age related inverse dose relation of sedatives and analgesics in the intensive care unit
Sedative and analgesic practices in intensive care units (ICUs) are frequently based on anesthesia regimes but do not take account of the important patient related factors. Pharmacologic properties of sedatives and analgesics change when used as continuous infusions in ICU compared to bolus or short-term infusions during anesthesia. In a prospective observational cohort study, we investigated the association between patient related factors and sedatives/analgesics doses in patients on mechanical ventilation (MV) and their association with cessation of sedation/analgesia. We included patients expected to receive MV for at least 24 hours and excluded those with difficulty in assessing the depth of sedation. We collected data for the first 72 hours or until extubation, whichever occurred first. Multivariate analysis of variance, multivariate regression as well as logistic regression were used. The final cohort (N = 576) was predominantly male (64%) with mean (SD) age 61.7 (15.6) years, weight 63.4 (18.2) Kg, Acute Physiology and Chronic Health Evaluation II score 28.2 (8) and 30% hospital mortality. Increasing age was associated with reduced propofol and fentanyl doses requirements, adjusted to the weight (p<0.001). Factors associated with higher propofol and fentanyl doses were vasopressor use (Relative mean difference (RMD) propofol 1.56 (95% confidence interval (CI) 1.28–1.90); fentanyl 1.48 (1.25–1.76) and central venous line placement (CVL, RMD propofol 1.64 (1.15–2.33); fentanyl 1.41 (1.03–1.91). Male gender was also associated with higher propofol dose (RMD 1.27 (1.06–1.49). Sedation cessation was less likely to occur in restrained patients (Odds Ratio, OR 0.48 (CI 0.30–0.78) or those receiving higher sedative/analgesic doses (OR propofol 0.98 (CI 0.97–0.99); fentanyl 0.99 (CI 0.98–0.997), independent of depth of sedation. In conclusion, increasing age is associated with the use of lower doses of sedative/analgesic in ICU, whereas CVL and vasopressor use were associated with higher doses.
- 28 September 2017
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (9) , e0185212
Open AccessAge related inverse dose relation of sedatives and analgesics in the intensive care unit
Sedative and analgesic practices in intensive care units (ICUs) are frequently based on anesthesia regimes but do not take account of the important patient related factors. Pharmacologic properties of sedatives and analgesics change when used as continuous infusions in ICU compared to bolus or short-term infusions during anesthesia. In a prospective observational cohort study, we investigated the association between patient related factors and sedatives/analgesics doses in patients on mechanical ventilation (MV) and their association with cessation of sedation/analgesia. We included patients expected to receive MV for at least 24 hours and excluded those with difficulty in assessing the depth of sedation. We collected data for the first 72 hours or until extubation, whichever occurred first. Multivariate analysis of variance, multivariate regression as well as logistic regression were used. The final cohort (N = 576) was predominantly male (64%) with mean (SD) age 61.7 (15.6) years, weight 63.4 (18.2) Kg, Acute Physiology and Chronic Health Evaluation II score 28.2 (8) and 30% hospital mortality. Increasing age was associated with reduced propofol and fentanyl doses requirements, adjusted to the weight (p<0.001). Factors associated with higher propofol and fentanyl doses were vasopressor use (Relative mean difference (RMD) propofol 1.56 (95% confidence interval (CI) 1.28–1.90); fentanyl 1.48 (1.25–1.76) and central venous line placement (CVL, RMD propofol 1.64 (1.15–2.33); fentanyl 1.41 (1.03–1.91). Male gender was also associated with higher propofol dose (RMD 1.27 (1.06–1.49). Sedation cessation was less likely to occur in restrained patients (Odds Ratio, OR 0.48 (CI 0.30–0.78) or those receiving higher sedative/analgesic doses (OR propofol 0.98 (CI 0.97–0.99); fentanyl 0.99 (CI 0.98–0.997), independent of depth of sedation. In conclusion, increasing age is associated with the use of lower doses of sedative/analgesic in ICU, whereas CVL and vasopressor use were associated with higher doses.
- Open Access
- 1 January 2017
- Published by Elsevier in Annals of Intensive Care
- Vol. 7 (1) , 120
Frequency and prognostic impact of basic critical care echocardiography abnormalities in patients with acute respiratory distress syndrome
- 1 January 2017
- Published by Elsevier in Annals of Intensive Care
- Vol. 7 (1) , 120
Open AccessFrequency and prognostic impact of basic critical care echocardiography abnormalities in patients with acute respiratory distress syndrome
- Open Access
- 12 October 2016
- Published by Springer Nature in Critical Care
- Vol. 20 (1) , 326
Nurse-performed screening for postextubation dysphagia: a retrospective cohort study in critically ill medical patients
Swallowing difficulties are common, and dysphagia occurs frequently in intensive care unit (ICU) patients after extubation. Yet, no guidelines on postextubation swallowing assessment exist. We aimed to investigate the safety and effectiveness of nurse-performed screening (NPS) for postextubation dysphagia in the medical ICU. We conducted a retrospective cohort study of mechanically ventilated patients who were extubated in a 20-bed medical ICU. Phase I (no NPS, October 2012 to January 2014) and phase II (NPS, February 2014 to July 2015) were compared. In phase II, extubated patients received NPS up to three times on consecutive days; patients who failed were referred to speech-language pathologists. Outcomes analyzed included oral feeding at ICU discharge, reintubation, ICU readmission, postextubation pneumonia, ICU and/or hospital mortality, and ICU and/or hospital length of stay (LOS). Subgroup analysis was done for patients extubated after >72 h of mechanical ventilation, as the latter may predispose patients to postextubation dysphagia. Multivariable adjustments for Acute Physiology and Chronic Health Evaluation (APACHE) II score and comorbidities were done because of baseline differences between the phases. A total of 468 patients were studied (281 in phase I, 187 in phase II). Patients in phase II had higher APACHE II scores than those in phase I (27.2 ± 8.2 vs. 25.4 ± 8.2; P = 0.018). Despite this, patients in phase II showed a 111 % increase in (the odds of) oral feeding at ICU discharge and a 59 % decrease in postextubation pneumonia (multivariate P values 0.001 and 0.006, respectively). In the subgroup analysis, NPS was associated with a 127 % increase in oral feeding at ICU discharge, an 80 % decrease in postextubation pneumonia, and a 25 % decrease in hospital LOS (multivariate P values 0.021, 0.004, and 0.009, respectively). No other outcome differences were found. NPS for dysphagia is safe and may be superior to no screening with respect to several patient-centered outcomes.
- 12 October 2016
- Published by Springer Nature in Critical Care
- Vol. 20 (1) , 326
Open AccessNurse-performed screening for postextubation dysphagia: a retrospective cohort study in critically ill medical patients
Swallowing difficulties are common, and dysphagia occurs frequently in intensive care unit (ICU) patients after extubation. Yet, no guidelines on postextubation swallowing assessment exist. We aimed to investigate the safety and effectiveness of nurse-performed screening (NPS) for postextubation dysphagia in the medical ICU. We conducted a retrospective cohort study of mechanically ventilated patients who were extubated in a 20-bed medical ICU. Phase I (no NPS, October 2012 to January 2014) and phase II (NPS, February 2014 to July 2015) were compared. In phase II, extubated patients received NPS up to three times on consecutive days; patients who failed were referred to speech-language pathologists. Outcomes analyzed included oral feeding at ICU discharge, reintubation, ICU readmission, postextubation pneumonia, ICU and/or hospital mortality, and ICU and/or hospital length of stay (LOS). Subgroup analysis was done for patients extubated after >72 h of mechanical ventilation, as the latter may predispose patients to postextubation dysphagia. Multivariable adjustments for Acute Physiology and Chronic Health Evaluation (APACHE) II score and comorbidities were done because of baseline differences between the phases. A total of 468 patients were studied (281 in phase I, 187 in phase II). Patients in phase II had higher APACHE II scores than those in phase I (27.2 ± 8.2 vs. 25.4 ± 8.2; P = 0.018). Despite this, patients in phase II showed a 111 % increase in (the odds of) oral feeding at ICU discharge and a 59 % decrease in postextubation pneumonia (multivariate P values 0.001 and 0.006, respectively). In the subgroup analysis, NPS was associated with a 127 % increase in oral feeding at ICU discharge, an 80 % decrease in postextubation pneumonia, and a 25 % decrease in hospital LOS (multivariate P values 0.021, 0.004, and 0.009, respectively). No other outcome differences were found. NPS for dysphagia is safe and may be superior to no screening with respect to several patient-centered outcomes.
- Open Access
- 28 August 2016
- Published by Springer Nature in Critical Care
- Vol. 20 (1) , 1-11
Severe community-acquired pneumonia: timely management measures in the first 24 hours
Mortality rates for severe community-acquired pneumonia (CAP) range from 17 to 48 % in published studies. In this review, we searched PubMed for relevant papers published between 1981 and June 2016 and relevant files. We explored how early and aggressive management measures, implemented within 24 hours of recognition of severe CAP and carried out both in the emergency department and in the ICU, decrease mortality in severe CAP. These measures begin with the use of severity assessment tools and the application of care bundles via clinical decision support tools. The bundles include early guideline-concordant antibiotics including macrolides, early haemodynamic support (lactate measurement, intravenous fluids, and vasopressors), and early respiratory support (high-flow nasal cannulae, lung-protective ventilation, prone positioning, and neuromuscular blockade for acute respiratory distress syndrome). While the proposed interventions appear straightforward, multiple barriers to their implementation exist. To successfully decrease mortality for severe CAP, early and close collaboration between emergency medicine and respiratory and critical care medicine teams is required. We propose a workflow incorporating these interventions.
- 28 August 2016
- Published by Springer Nature in Critical Care
- Vol. 20 (1) , 1-11
Open AccessSevere community-acquired pneumonia: timely management measures in the first 24 hours
Mortality rates for severe community-acquired pneumonia (CAP) range from 17 to 48 % in published studies. In this review, we searched PubMed for relevant papers published between 1981 and June 2016 and relevant files. We explored how early and aggressive management measures, implemented within 24 hours of recognition of severe CAP and carried out both in the emergency department and in the ICU, decrease mortality in severe CAP. These measures begin with the use of severity assessment tools and the application of care bundles via clinical decision support tools. The bundles include early guideline-concordant antibiotics including macrolides, early haemodynamic support (lactate measurement, intravenous fluids, and vasopressors), and early respiratory support (high-flow nasal cannulae, lung-protective ventilation, prone positioning, and neuromuscular blockade for acute respiratory distress syndrome). While the proposed interventions appear straightforward, multiple barriers to their implementation exist. To successfully decrease mortality for severe CAP, early and close collaboration between emergency medicine and respiratory and critical care medicine teams is required. We propose a workflow incorporating these interventions.
- 12 April 2016
- Published by Springer Nature in Intensive Care Medicine
- Vol. 42 (7) , 1118-1127
Withholding and withdrawal of life-sustaining treatments in low-middle-income versus high-income Asian countries and regions
To compare the attitudes of physicians towards withholding and withdrawing life-sustaining treatments in intensive care units (ICUs) in low-middle-income Asian countries and regions with those in high-income ones, and to explore differences in the role of families and surrogates, legal risks, and financial considerations between these countries and regions. Questionnaire study conducted in May–December 2012 on 847 physicians from 255 ICUs in 10 low-middle-income countries and regions according to the World Bank’s classification, and 618 physicians from 211 ICUs in six high-income countries and regions. After we accounted for personal, ICU, and hospital characteristics on multivariable analyses using generalised linear mixed models, physicians from low-middle-income countries and regions were less likely to limit cardiopulmonary resuscitation, mechanical ventilation, vasopressors and inotropes, tracheostomy and haemodialysis than those from high-income countries and regions. They were more likely to involve families in end-of-life care discussions and to perceive legal risks with limitation of life-sustaining treatments and do-not-resuscitate orders. Nonetheless, they were also more likely to accede to families’ requests to withdraw life-sustaining treatments in a patient with an otherwise reasonable chance of survival on financial grounds in a case scenario (adjusted odds ratio 5.05, 95 % confidence interval 2.69–9.51, P < 0.001). Significant differences in ICU physicians’ self-reported practice of limiting life-sustaining treatments, the role of families and surrogates, perception of legal risks and financial considerations exist between low-middle-income and high-income Asian countries and regions.
- 12 April 2016
- Published by Springer Nature in Intensive Care Medicine
- Vol. 42 (7) , 1118-1127
Withholding and withdrawal of life-sustaining treatments in low-middle-income versus high-income Asian countries and regions
To compare the attitudes of physicians towards withholding and withdrawing life-sustaining treatments in intensive care units (ICUs) in low-middle-income Asian countries and regions with those in high-income ones, and to explore differences in the role of families and surrogates, legal risks, and financial considerations between these countries and regions. Questionnaire study conducted in May–December 2012 on 847 physicians from 255 ICUs in 10 low-middle-income countries and regions according to the World Bank’s classification, and 618 physicians from 211 ICUs in six high-income countries and regions. After we accounted for personal, ICU, and hospital characteristics on multivariable analyses using generalised linear mixed models, physicians from low-middle-income countries and regions were less likely to limit cardiopulmonary resuscitation, mechanical ventilation, vasopressors and inotropes, tracheostomy and haemodialysis than those from high-income countries and regions. They were more likely to involve families in end-of-life care discussions and to perceive legal risks with limitation of life-sustaining treatments and do-not-resuscitate orders. Nonetheless, they were also more likely to accede to families’ requests to withdraw life-sustaining treatments in a patient with an otherwise reasonable chance of survival on financial grounds in a case scenario (adjusted odds ratio 5.05, 95 % confidence interval 2.69–9.51, P < 0.001). Significant differences in ICU physicians’ self-reported practice of limiting life-sustaining treatments, the role of families and surrogates, perception of legal risks and financial considerations exist between low-middle-income and high-income Asian countries and regions.